Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
Titel:
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
Auteur:
Denys, Hannelore Martinez-Mena, Corina L. Martens, Marc T. D’Hondt, Randal G. Graas, Marie-Pascale L. Evron, Ella Fried, Georgeta Ben-Baruch, Noa E. Vulsteke, Christof Van Steenberghe, Mona M.